PCRX

PCRX EBITDA Margin

15.38%TTM

Period ending:

PCRX FY EBITDA Margin%
PCRX FY EBITDA Margin61.44%-336.79%
2008-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

PCRX ebitda margin history

EBITDA as a percentage of revenue. The available annual fiscal periods series contains 18 observations from Dec 31, 2008 to Dec 31, 2025.

Pacira Biosciences Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
16.8641%
4.154%
22.9022%
21.0519%
21.0417%
14.7824%
7.3033%
9.8005%
-3.695%
-6.4638%
8.5909%
2.5765%
-59.2956%
-113.9801%
-218.2038%
-131.2938%
-160.709%
-298.2549%

Compare ebitda margin

All PCRX financial metrics · PCRX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.